8F4V | pdb_00008f4v

Alpha7 nicotinic acetylcholine receptor intracellular and transmembrane domains bound to ivermectin in a desensitized state


SOLUTION NMR
NMR Experiment
ExperimentTypeSample ContentsSolventIonic StrengthpHPressureTemperature (K)Spectrometer
12D 1H-15N TROSY-HSQC0.25 mM [U-15N] alpha7nAChR C317 TMD+ICD, 5 mM sodium acetate, 35 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
22D 1H-15N TROSY-HSQC0.25 mM [U-15N] alpha7nAChR C317 TMD+ICD, 5 mM sodium acetate, 35 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS, 30 uM ivermectin, 0.1 % DMSO95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
32D 1H-15N TROSY-HSQC0.25 mM [U-15N] alpha7nAChR C317 TMD+ICD, 5 mM sodium acetate, 35 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS, 100 uM ivermectin, 0.3 % DMSO95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
42D 1H-15N TROSY-HSQC0.25 mM [U-15N] alpha7nAChR C317 TMD+ICD, 5 mM sodium acetate, 35 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS, 250 uM ivermectin, 0.55 % DMSO95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
52D 1H-15N TROSY-HSQC0.25 mM [U-15N] alpha7nAChR C317 TMD+ICD, 5 mM sodium acetate, 35 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS, 500 uM ivermectin, 0.95 % DMSO95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
62D 1H-15N STD TROSY-HSQC0.25 mM [U-15N] alpha7nAChR C317 TMD+ICD, 5 mM sodium acetate, 35 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS, 500 uM ivermectin, 0.8 % DMSO95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
72D 1H-15N STD TROSY-HSQC0.25 mM [U-15N] alpha7nAChR C317 TMD+ICD, 5 mM sodium acetate, 35 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS, 500 uM ivermectin, 0.8 % DMSO95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
82D 1H-15N STD TROSY-HSQC0.25 mM [U-15N] alpha7nAChR C317 TMD+ICD, 5 mM sodium acetate, 35 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS, 500 uM ivermectin, 0.8 % DMSO95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
92D NOESY0.20 mM [U-15N] alpha7nAChR C317 TMD+ICD, 5 mM sodium acetate, 35 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS, 500 uM ivermectin, 0.8 % DMSO95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
102D 1H-15N TROSY-HSQC0.22 mM [U-15N] V311C-MTSL alpha7nAChR TMD+ICD, 5 mM sodium acetate, 35 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS, 220 uM ivermectin, 0.4 % DMSO95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
112D 1H-15N TROSY-HSQC0.22 mM [U-15N] V311C-MTSL alpha7nAChR TMD+ICD, 5 mM sodium acetate, 35 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
122D 1H-15N TROSY-HSQC0.22 mM [U-15N] C335-MTSL alpha7nAChR TMD+ICD, 5 mM sodium acetate, 26 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS, 220 uM ivermectin, 0.4 % DMSO95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
132D 1H-15N TROSY-HSQC0.22 mM [U-15N] C335-MTSL alpha7nAChR TMD+ICD, 5 mM sodium acetate, 26 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
142D 1H-15N TROSY-HSQC0.2 mM [U-15N] C342-MTSL alpha7nAChR TMD+ICD, 5 mM sodium acetate, 26 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS, 200 uM ivermectin, 0.4 % DMSO95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
152D 1H-15N TROSY-HSQC0.2 % [U-15N] C342-MTSL alpha7nAChR TMD+ICD, 5 mM sodium acetate, 26 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
162D 1H-15N TROSY-HSQC0.2 mM [U-15N] S350C-MTSL alpha7nAChR TMD+ICD, 5 mM sodium acetate, 44 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS, 200 uM ivermectin, 0.4 % DMSO95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
172D 1H-15N TROSY-HSQC0.2 mM [U-15N] S350C-MTSL alpha7nAChR TMD+ICD, 5 mM sodium acetate, 44 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
182D 1H-15N TROSY-HSQC0.2 mM [U-15N] C375-MTSL alpha7nAChR TMD+ICD, 5 mM sodium acetate, 35 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS, 200 uM ivermectin, 0.4 % DMSO95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
192D 1H-15N TROSY-HSQC0.2 mM [U-15N] C375-MTSL alpha7nAChR TMD+ICD, 5 mM sodium acetate, 35 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
202D 1H-15N TROSY-HSQC0.25 mM [U-15N] C390-MTSL alpha7nAChR TMD+ICD, 5 mM sodium acetate, 44 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS, 250 uM ivermectin, 0.4 % DMSO95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
212D 1H-15N TROSY-HSQC0.25 mM [U-15N] C390-MTSL alpha7nAChR TMD+ICD, 5 mM sodium acetate, 44 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
222D 1H-15N TROSY-HSQC0.24 mM [U-15N] L415C-MTSL alpha7nAChR TMD+ICD, 5 mM sodium acetate, 35 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS, 240 uM ivermectin, 0.4 % DMSO95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
232D 1H-15N TROSY-HSQC0.24 mM [U-15N] L415C-MTSL alpha7nAChR TMD+ICD, 5 mM sodium acetate, 35 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
242D 1H-15N TROSY-HSQC0.2 mM [U-15N] C435-MTSL alpha7nAChR TMD+ICD, 5 mM sodium acetate, 22 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS, 200 uM ivermectin, 0.4 % DMSO95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
252D 1H-15N TROSY-HSQC0.2 mM [U-15N] C435-MTSL alpha7nAChR TMD+ICD, 5 mM sodium acetate, 22 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
263D TROSY-HNCO0.22 mM [U-13C; U-15N] alpha7nAChR C317 TMD+ICD, 5 mM sodium acetate, 44 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS, 30 uM ivermectin, 30 uM PNU, 0.2 % DMSO95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
273D TROSY-HNCO0.22 mM [U-13C; U-15N] alpha7nAChR C317 TMD+ICD, 5 mM sodium acetate, 44 mM LDAO, 25 mM sodium chloride, 5 % D2O, 20 uM DSS95% H2O/5% D2O25 mM4.71 atm318Bruker AVANCE II 800
NMR Spectrometer Information
SpectrometerManufacturerModelField Strength
1BrukerAVANCE II800
NMR Refinement
MethodDetailsSoftware
naRosetta
na
NMR Ensemble Information
Conformer Selection Criteriastructures with the lowest energy
Conformers Calculated Total Number1000
Conformers Submitted Total Number15
Representative Model1 (lowest energy)
Computation: NMR Software
#ClassificationVersionSoftware NameAuthor
1collectionTopSpin3.2Bruker Biospin
2processingNMRPipe10.9Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3data analysisSparky3.190Goddard
4data analysisNMRFAM-SPARKY1.470Lee, Tonelli and Markley
5structure calculationCS-ROSETTA3.17Shen, Vernon, Baker and Bax
6structure calculationRosetta3.7Leaver-Fay, Tyka, Lewis, Lange, Thompson, Jacak, Kaufman, Renfrew, Smith, Sheffler, Davis, Cooper, Treuille, Mandell, Richter, Ban, Fleishman, Corn, Kim, Lyskov, Berrondo, Mentzer, Popovic, Havranek, Karanicolas, Das, Meiler, Kortemme, Gray, Kuhlman, Baker, and Bradley
7refinementRosetta3.7Leaver-Fay, Tyka, Lewis, Lange, Thompson, Jacak, Kaufman, Renfrew, Smith, Sheffler, Davis, Cooper, Treuille, Mandell, Richter, Ban, Fleishman, Corn, Kim, Lyskov, Berrondo, Mentzer, Popovic, Havranek, Karanicolas, Das, Meiler, Kortemme, Gray, Kuhlman, Baker, and Bradley
9refinementMolProbityRichardson